|Bid||26.00 x 3200|
|Ask||26.50 x 800|
|Day's Range||26.31 - 26.49|
|52 Week Range||24.05 - 27.95|
|Beta (5Y Monthly)||0.77|
|PE Ratio (TTM)||323.05|
|Forward Dividend & Yield||2.09 (7.94%)|
|Ex-Dividend Date||Sep 30, 2021|
|1y Target Est||N/A|
Subscribe to Yahoo Finance Plus to view Fair Value for XOMAOLearn more
With its stock down 22% over the past three months, it is easy to disregard XOMA (NASDAQ:XOMA). However, the company's...
In this article, we discuss the 10 best biotech stocks to buy according to Mark Lampert. You can skip our detailed analysis of Lampert’s Biotechnology Value Fund, and go directly to the 5 Best Biotech Stocks to Buy According to Mark Lampert’s Biotechnology Value Fund. Mark Lampert is an American investor who founded BVF Partners Ltd. […]
Xoma (XOMA) delivered earnings and revenue surprises of -466.67% and -85.22%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?